Dana Vigier, VP and Central and Northern Europe Area Head at Alexion, AstraZeneca Rare Disease, shares her views on a holistic approach to rare diseases. She emphasises the importance of listening to the voices of rare disease patients and ensuring they have access to the best treatment options.
In an exclusive interview with Michelle Melka, Director of Global Product Strategy, Digital Transformation at BioMarin, we delve into the changing landscape of pharmaceutical marketing. Melka emphasizes the importance of a patient-centric approach and highlights how BioMarin is evolving its digital capabilities to meet customer preferences. Learn about the challenges faced in providing accurate and accessible information, especially in the realm of rare diseases. Melka also discusses the company’s ambitions for powerful digital transformation and the future of content and omnichannel strategies in building meaningful relationships with healthcare professionals. Don’t miss the insights from this industry leader as she shares her vision for the future of pharma marketing.
Interview with Philip Pisa, Director, Digital Marketing and Innovation at Roche “The best omnichannel strategy is the one that it is actually possible to implement,” says Philip Pisa, Director, Digital Marketing and Innovation at Roche. Philip will attend the Reuters Pharma Customer Engagement Europe 2023 event, which runs from 9–10 November in London, and will …
Interview with Panos Papakonstantinou, Global Engagement Catalyst Leader at Roche Panos Papakonstantinou, the Global Engagement Catalyst Leader at Roche, will speak at November’s NEXT Pharma CX & Engagement Summit 2023 in Vienna, Austria, in a session entitled ‘Unlocking the power of CX for authentic and meaningful engagements.’ SciencePOD had the opportunity to speak with Panos …
Scientific dissemination is vital in communicating research findings to a broader demographic, ensuring that scientific advancements are understood and utilised effectively. This process entails simplifying complex scientific ideas into accessible language that both specialists and the general public can comprehend. Through various channels such as publications, social media, and public lectures, scientific dissemination fosters public understanding of science, enhances scientific literacy, and encourages informed decision-making. This, in turn, supports the progression of scientific knowledge, transparency, and collaboration, which are indispensable for societal development and innovation.
The pandemic has uncovered new Digital publishing opportunities These are no ordinary times. We face a pandemic together and we are all trying to grasp how we will be affected now and into the future. As we look to make sense of this public health emergency, people’s appetite for information grows along with the belief or …
Pandemic Reveals New All-Digital Publishing Opportunities Read More »
SciencePOD benefits research impact expansion SciencePOD offers Asia Pacific scientists new opportunities to increase their research impact and engage global audiences through access to the most trusted science content marketing platform SciencePODis pleased to announce it has partnered with iGroup as its agent in the Asia Pacific region. By introducing SciencePOD’s cloud-based science content marketing …
SciencePOD Helps iGroup Expand its Research Impact Read More »